A statistical model to describe longitudinal and correlated metabolic risk factors: the Whitehall II prospective study.

scientific article published in December 2016

A statistical model to describe longitudinal and correlated metabolic risk factors: the Whitehall II prospective study. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/PUBMED/FDV160
P8608Fatcat IDrelease_ztxxaflkkrbotg4cjgylxgpoju
P932PMC publication ID6092879
P698PubMed publication ID28158533
P5875ResearchGate publication ID283576155

P50authorPeter DiggleQ16728567
Adam G TabakQ57353570
P2093author name stringJ Chilcott
E Brunner
H Squires
A Brennan
C Stride
P Breeze
P2860cites workModelling the lifetime costs and health effects of lifestyle intervention in the prevention and treatment of obesity in SwitzerlandQ46680488
HbA1c 5·7-6·4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study.Q51371579
Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternativesQ56885135
Cohort Profile: The Whitehall II studyQ57241528
Social inequality in coronary risk: Central obesity and the metabolic syndrome. Evidence from the Whitehall II studyQ57241659
Five-year changes in biologic risk factors and risk of type 2 diabetes: are attained but not initial risk factor levels of importance?Q87381148
General cardiovascular risk profile for use in primary care: the Framingham Heart StudyQ29614189
UKPDS outcomes model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82.Q30651159
Longitudinal paths to the metabolic syndrome: can the incidence of the metabolic syndrome be predicted? The Baltimore Longitudinal Study of AgingQ33597936
Weight change over five-year periods and number of components of the metabolic syndrome in a Dutch cohortQ33651745
The Preventable Risk Integrated ModEl and Its Use to Estimate the Health Impact of Public Health Policy ScenariosQ34330864
Age trajectories of physiological indices in relation to healthy life courseQ34723225
Clinical Impact of the New Criteria for the Diagnosis of Diabetes MellitusQ35576094
Population heterogeneity in trajectories of midlife blood pressureQ35969227
Association of adiposity trajectories with insulin sensitivity and glycemic deterioration: a longitudinal study of rural Chinese twin adultsQ36047326
Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysisQ36672238
Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2.Q36738148
Prediabetes: a high-risk state for diabetes development.Q37476370
Modelling the economics of type 2 diabetes mellitus prevention: a literature review of methodsQ38193335
Central obesity as a precursor to the metabolic syndrome in the AusDiab study and MauritiusQ40042183
A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68).Q40471646
Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test?Q43960351
Trajectories of cardiometabolic risk factors before diagnosis of three subtypes of type 2 diabetes: a post-hoc analysis of the longitudinal Whitehall II cohort study.Q45497146
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue4
P921main subjectstatisticsQ12483
P304page(s)679-687
P577publication date2016-12-01
P1433published inJournal of Public HealthQ15754594
P1476titleA statistical model to describe longitudinal and correlated metabolic risk factors: the Whitehall II prospective study.
P478volume38

Reverse relations

cites work (P2860)
Q47124235Assessing the potential return on investment of the proposed UK NHS diabetes prevention programme in different population subgroups: an economic evaluation
Q40292084Cost-effectiveness of population-based, community, workplace and individual policies for diabetes prevention in the UK.
Q90023140Modeling of Diabetes and Its Clinical Impact
Q40376763The impact of Type 2 diabetes prevention programmes based on risk-identification and lifestyle intervention intensity strategies: a cost-effectiveness analysis.

Search more.